Trifork Group (TRIFOR) Q4 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2024 earnings summary
2 Dec, 2025Executive summary
Q4 2024 delivered record or near-record revenue, with sequential improvement in growth and margins, but full-year revenue was slightly down due to weak Q2/Q3 performance.
The company retained 18 of its top 20 customers since IPO and expanded in both private and public sectors, with a strategic focus on product-led growth and bundling IP and services.
U.S. operations saw strong growth, with Q4 revenue up 69.9% year-over-year, driven by targeted product offerings and successful lead conversion.
Cost savings program initiated in Q3 2024 is progressing, with full EBITDA effect expected by mid-2025.
Strategic partnerships, product/platform sales expansion, and cross-selling are key 2025 priorities.
Financial highlights
Q4 2024 revenue was EUR 56.0m (+1.8% YoY); full-year 2024 revenue was EUR 205.9m, slightly down from EUR 207.9m in 2023.
Adjusted EBITDA for 2024 was EUR 26.9m (13.1% margin), with Q4 at EUR 9.0m (16.1% margin); net income for 2024 was EUR 17.9m.
Net debt at year-end was EUR 45.9m; leverage ratio 1.9x NIBD/Adj. EBITDA.
Labs segment EBT contributed EUR 15.6m, driven by fair value gains and strong profit.
Free cash flow for 2024 was EUR 11.4m, down from EUR 18.1m in 2023.
Outlook and guidance
2025 revenue guidance is EUR 215–225m (4.4–9.3% total growth, 2.9–7.8% organic), with adjusted EBITDA guidance of EUR 32–37m (14.2–17.2% margin).
Mid-term (2024–2026) target: 10–15% annual growth, 5–10% organic growth, 16–20% EBITDA margin.
Cost-saving program aims for €10 million in annualized savings, with full impact expected by Q3/Q4 2025.
Guidance is considered conservative, reflecting lessons from 2024 and ongoing investments in business development.
Inorganic growth in 2025 expected at ~EUR 3m from announced acquisitions.
Latest events from Trifork Group
- Record 2025 revenue, strong product growth, margin gains, and robust 2026 outlook.TRIFOR
Q4 202527 Feb 2026 - Revenue up 7.3% to EUR 220.9M, strong product growth, margin recovery, and robust outlook.TRIFOR
Q4 202527 Feb 2026 - Revenue and margins fell, but public sector momentum and Labs gains support future outlook.TRIFOR
Q2 202423 Jan 2026 - Product-driven growth, innovation in AI and digital health, and strong 2025 financial targets.TRIFOR
Danske Bank Winter Seminar presentation19 Jan 2026 - Revenue and margins fell in 2024, triggering cost cuts and growth in US and public sector Denmark.TRIFOR
Q3 202417 Jan 2026 - Q2 2025 revenue up 5.1%, with product focus and digital health wins fueling future growth.TRIFOR
Investor presentation16 Jan 2026 - Product-driven growth, innovation in AI, and strong 2025 financial targets define the outlook.TRIFOR
Investor presentation16 Jan 2026 - Product-led transformation, robust 2025 outlook, and strong Labs investment performance.TRIFOR
SEB Nordic Seminar presentation16 Jan 2026 - Labs portfolio value reaches EUR 84m, with strong exits and high-growth companies driving returns.TRIFOR
Investor update13 Jan 2026